Newsletter | May 19, 2026

Cell And Gene Therapies: The Emerging Reality For Scalable Market Readiness

SPONSOR

Webinar: CAR-T Strategy in 2026: Scaling Autologous, Advancing Allogeneic

Explore what's next for CAR-T in this Thermo Fisher Scientific expert panel. As autologous therapies expand and allogeneic approaches advance, leaders discuss strategy across R&D, manufacturing, and commercialization. Gain insights into regulatory expectations, scalability, access, and supply chain models shaping CAR-T development in 2026 and beyond, highlighting challenges, opportunities, and priorities driving innovation across the evolving cell therapy landscape. Click here to learn more.

FOCUS ON MANUFACTURING

Cell And Gene Therapies: The Emerging Reality For Scalable Market Readiness

Mainstream biopharma’s commercialization playbook isn’t working for cell and gene therapies. Orgs that invest in scalable platforms (and more) will see better success.

FOCUS ON MANUFACTURING

Form Fill And Seal Label Applicator For Drug Packaging

Examine a reliable solution for vertical and horizontal form fill and seal machine labeling, designed to improve throughput and accuracy within your existing drug packaging infrastructure.

How AI Is Streamlining Cell And Gene Therapy Manufacturing

Artificial intelligence is transforming the manufacturing landscape. See how quality data and real-time monitoring accelerate production to deliver life-saving treatments to more patients.

Fluid Connection Technologies For Sterile Fill and Finish Process Design

Single-use technology and innovative fluid connections play a significant role in creating an effective, sterile fill and finish operation that maintains the integrity of your biologic products.

Streamlined dPCR Workflow For Lentiviral Characterization

Discover a streamlined dPCR-based workflow for precise lentiviral vector quantification to support safer, more consistent cell and gene therapies through accurate genome titer, VCN, and RCL assessment.

How Tunable Cell Processing Solutions Ensure Separation Efficiency

Single-use tubular bowl centrifuges are standing out to cell therapy developers for their ability enable the optimal balance between high separation efficiency, high productivity, and low shear.

Mold In Cleanrooms: A Persistent Threat And Case For Proactive Decontamination

Learn how a comprehensive investigation and systems-level bio-decontamination strategy successfully eliminated persistent mold contamination in a vaccine manufacturing facility's high-risk area.

Capsules Versus Hollow Fibers For Ultrafiltration/Diafiltration (UF/DF)

Explore the performance evaluation of a first-of-its-kind spiral-wound TFF filter versus hollow fibers for UF/DF of viral vectors and the impact of either filter type on a TFF process.

Freeze, Thaw, And Expand: Scale-Up T Cell Workflow In Chemically Defined Media

A chemically defined T cell workflow improves reproducibility and supports robust expansion in both static and bioreactor scale-up systems, while allowing for the elimination of the post-thaw wash step.

The Rise In Aseptic Manufacturing Solutions With Smaller Footprints

Aseptic drug manufacturing is going small. Uncover how advanced robotic and automated systems with smaller footprints are changing the landscape and boosting accessibility.

MANUFACTURING SOLUTIONS

Accelerate Manufacturing With GMP-Compliant Automation Solutions - Invetech

How It Works: Operation Of Fragment Analyzer Systems - Agilent Technologies

Sterile Filtration And Clarification - Cytiva

Streamline Your Cell Therapy Manufacturing - Cytiva

New GMP-Grade Endonuclease For VV Manufacturing - Roche CustomBiotech

Oligonucleotides LC-MS: Support From Development To Release - Solvias

Connect With Cell & Gene: